SPOC Proteomics Inc. is pioneering breakthroughs in proteomics with its foundational Sensor-Integrated Proteome on Chip (SPOC) technology. SPOC solves two key challenges (i) producing thousands of full-length, properly folded proteins and (ii) measurement of affinities and other kinetic parameters, at 10 - 100x lower costs compared to current methods. This is proprietary technology with 18+ issued and pending patents. SPOC Proteomics' first-of-kind high plex technology enables rapid testing and down selection of leads in pre-clinical development, wet lab testing and validation of AI designed drug molecules based on objective data, and generating large proprietary data sets to train AI models. Follow on markets include plasma proteomics for precision biomarker discovery and diagnostics, addressing a $75B proteomics market. We are currently advancing discussions with select partners on paid early-access pilot projects, targeting use cases with substantial recurring revenue potential.